USA • New York Stock Exchange • NYSE:HQH • US87911J1034
The current stock price of HQH is 19.33 USD. In the past month the price increased by 2.44%. In the past year, price increased by 8.29%.
ChartMill assigns a technical rating of 6 / 10 to HQH. When comparing the yearly performance of all stocks, HQH turns out to be only a medium performer in the overall market: it outperformed 62.99% of all stocks.
abrdn Healthcare Investors is a US-based company operating in industry. The company is headquartered in Philadelphia, Pennsylvania. abrdn Healthcare Investors (the Fund) is a non-diversified closed-end management investment company. The Fund's investment objective is to seek long-term capital appreciation by investing primarily in securities of healthcare companies. In addition, it seeks to provide regular distribution of realized capital gains. The company may invest up to 20% of its net assets in securities of foreign issuers, located primarily in Western Europe, Canada and Japan, and securities of United States issuers that are traded in foreign markets. The company invests in healthcare industries and is focused on the smaller, emerging companies, investing a maximum of 40% of the Fund's assets in restricted securities of both public and private companies. The company invests in subsectors, such as biotechnology, pharmaceuticals, healthcare equipment, healthcare supplies, life sciences tools and services, healthcare distributors, managed healthcare and others. abrdn Inc. is the investment adviser of the Fund.
The current stock price of HQH is 19.33 USD. The price increased by 1.2% in the last trading session.
HQH has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
HQH stock is listed on the New York Stock Exchange exchange.